Author Correction: BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCRABL1 kinase inhibition

"In the version of this article initially published, the panel Adriamycin/BCL6+/+ in Fig. 2d represents another image of the Control/BCL6/ condition. The error occurred during figure assembly and did not affect the calculation of mean values and s.d. Our own image analysis, not available at the time of publication, revealed that the panel SFO2/Imatinib in Supplementary Fig. 21 contained an inadvertent duplication."

"The corrected figure panels are provided below as Figs. 1 and 2. The original raw image and flow cytometry files have been published via Mendeley Data1. This notice serves to amend the errors."

BCL6 expression permits Philadelphia chromosome–positive acute lymphoblastic leukaemia (Ph+ ALL) cells to survive inhibition of the BCRABL1 kinase. In the published figures, the Adriamycin/BCL6+/+ panel in Fig. 2d duplicated the Control/BCL6/ image during figure assembly. The error did not affect the calculation of mean values and standard deviations. Subsequent image analysis identified an inadvertent duplication in the SFO2/Imatinib panel of Supplementary Fig. 21. Corrected figure panels are provided for Figs. 1 and 2. Original raw images and flow cytometry files have been deposited in Mendeley Data to replace the incorrect panels.

Read at www.nature.com